IN2015DN02377A - - Google Patents
Info
- Publication number
- IN2015DN02377A IN2015DN02377A IN2377DEN2015A IN2015DN02377A IN 2015DN02377 A IN2015DN02377 A IN 2015DN02377A IN 2377DEN2015 A IN2377DEN2015 A IN 2377DEN2015A IN 2015DN02377 A IN2015DN02377 A IN 2015DN02377A
- Authority
- IN
- India
- Prior art keywords
- luliconazole
- derivative
- pharmaceutical composition
- composition containing
- amide
- Prior art date
Links
- YTAOBBFIOAEMLL-REQDGWNSSA-N Luliconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@H](CS\1)SC/1=C(\C#N)N1C=NC=C1 YTAOBBFIOAEMLL-REQDGWNSSA-N 0.000 abstract 3
- 229960000570 luliconazole Drugs 0.000 abstract 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- -1 amide derivative of luliconazole Chemical class 0.000 abstract 1
- 150000001408 amides Chemical group 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
- 239000003589 local anesthetic agent Substances 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012203293 | 2012-09-14 | ||
| PCT/JP2013/073731 WO2014042043A1 (en) | 2012-09-14 | 2013-08-28 | Pharmaceutical composition containing luliconazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN02377A true IN2015DN02377A (cs) | 2015-09-04 |
Family
ID=49226452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2377DEN2015 IN2015DN02377A (cs) | 2012-09-14 | 2013-08-28 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20150238606A1 (cs) |
| EP (1) | EP2895164A1 (cs) |
| JP (2) | JP5686874B2 (cs) |
| CN (1) | CN104619320A (cs) |
| IN (1) | IN2015DN02377A (cs) |
| RU (1) | RU2621615C2 (cs) |
| WO (1) | WO2014042043A1 (cs) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5688406B2 (ja) | 2009-04-09 | 2015-03-25 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
| WO2010117089A2 (en) | 2009-04-09 | 2010-10-14 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| EP2470178B1 (en) | 2009-08-25 | 2018-10-17 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| US8962669B2 (en) | 2010-06-11 | 2015-02-24 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| JP6265624B2 (ja) * | 2012-05-11 | 2018-01-24 | ロート製薬株式会社 | ルリコナゾール含有外用医薬組成物 |
| WO2014041846A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal |
| CN104619703A (zh) | 2012-09-14 | 2015-05-13 | 宝丽制药股份有限公司 | 具有结晶习性的晶体以及通过对所述晶体进行加工获得的药物组合物 |
| JP5460797B1 (ja) * | 2012-09-14 | 2014-04-02 | 株式会社ポーラファルマ | アミド誘導体及び安定性指標としてのその使用 |
| WO2014042231A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Crystal and pharmaceutical preparation containing the same crystal |
| JP5589110B1 (ja) | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| JP6503627B2 (ja) * | 2013-03-28 | 2019-04-24 | 大正製薬株式会社 | 医薬液体組成物 |
| JP5680161B1 (ja) | 2013-09-06 | 2015-03-04 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| JP6242655B2 (ja) * | 2013-10-29 | 2017-12-06 | リンテック株式会社 | 機能性物質の放出方法、機能性物質の放出用キット及び放出性組成物 |
| JP5587488B1 (ja) | 2013-12-12 | 2014-09-10 | 株式会社ポーラファルマ | ルリコナゾールを含有する製剤の評価方法及び指標物質 |
| WO2017203456A1 (en) * | 2016-05-25 | 2017-11-30 | Glenmark Pharmaceuticals Limited | Luliconazole stable topicalcompositions |
| CN107865825B (zh) * | 2016-09-28 | 2022-05-20 | 四川海思科制药有限公司 | 一种卢立康唑外用喷雾剂药物组合物及其制备方法 |
| CN108934161A (zh) * | 2017-03-29 | 2018-12-04 | 日本农药株式会社 | 用于治疗感染症的医药组合物 |
| CN111295202B (zh) * | 2017-10-30 | 2022-07-08 | 科研制药株式会社 | 治疗甲癣的外用制剂 |
| CN108143711A (zh) * | 2018-01-13 | 2018-06-12 | 天津双硕医药科技有限公司 | 一种含有卢立康唑的外用乳膏组合物 |
| US10898470B1 (en) * | 2019-08-13 | 2021-01-26 | Sato Pharmaceutical Co., Ltd. | Pharmaceutical composition containing antifungal agent as active ingredient |
| CN113774390B (zh) * | 2021-08-12 | 2023-08-04 | 上海新阳半导体材料股份有限公司 | 一种用于化学机械抛光后的清洗液及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2645070C (en) * | 2006-03-08 | 2014-02-04 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
| EP2025337B1 (en) | 2006-03-08 | 2014-09-10 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
| US8058303B2 (en) | 2006-03-08 | 2011-11-15 | Nihon Nohyaku Co, Ltd | Pharmaceutical composition for external use |
| CN101820877B (zh) * | 2007-08-27 | 2013-09-11 | 日本农药株式会社 | 用于真菌性皮炎的药剂 |
| JP5453093B2 (ja) | 2007-09-05 | 2014-03-26 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
| JP5345937B2 (ja) | 2007-09-05 | 2013-11-20 | 株式会社ポーラファルマ | 抗真菌組成物 |
| WO2009031642A1 (ja) * | 2007-09-05 | 2009-03-12 | Pola Pharma Inc. | 医薬組成物 |
| US20090130232A1 (en) * | 2007-11-20 | 2009-05-21 | Mohammed Zahra | Composition and method for treatment of oral inflammation an ulceration |
| US8445717B2 (en) * | 2008-11-20 | 2013-05-21 | Chd Bioscience, Inc. | α-Keto alkylperacids and methods for producing and using the same |
| CN102395274B (zh) * | 2009-02-13 | 2014-03-12 | 托派卡医药股份有限公司 | 抗真菌制剂 |
| JP5688406B2 (ja) * | 2009-04-09 | 2015-03-25 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
| WO2010117089A2 (en) * | 2009-04-09 | 2010-10-14 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| EP2470178B1 (en) * | 2009-08-25 | 2018-10-17 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| US8962669B2 (en) * | 2010-06-11 | 2015-02-24 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| MX2013009175A (es) * | 2011-02-17 | 2013-08-29 | Chd Bioscience Inc | Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas. |
-
2013
- 2013-08-28 WO PCT/JP2013/073731 patent/WO2014042043A1/en active Application Filing
- 2013-08-28 CN CN201380047768.8A patent/CN104619320A/zh active Pending
- 2013-08-28 JP JP2013176862A patent/JP5686874B2/ja not_active Expired - Fee Related
- 2013-08-28 US US14/427,890 patent/US20150238606A1/en not_active Abandoned
- 2013-08-28 EP EP13765810.0A patent/EP2895164A1/en not_active Ceased
- 2013-08-28 RU RU2015108930A patent/RU2621615C2/ru not_active IP Right Cessation
- 2013-08-28 IN IN2377DEN2015 patent/IN2015DN02377A/en unknown
-
2014
- 2014-03-19 JP JP2014056829A patent/JP6215102B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014111672A (ja) | 2014-06-19 |
| CN104619320A (zh) | 2015-05-13 |
| EP2895164A1 (en) | 2015-07-22 |
| JP2014074012A (ja) | 2014-04-24 |
| RU2015108930A (ru) | 2016-11-10 |
| JP5686874B2 (ja) | 2015-03-18 |
| JP6215102B2 (ja) | 2017-10-18 |
| WO2014042043A1 (en) | 2014-03-20 |
| US20150238606A1 (en) | 2015-08-27 |
| WO2014042043A9 (en) | 2015-05-21 |
| RU2621615C2 (ru) | 2017-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN02377A (cs) | ||
| MX2019009176A (es) | Formulaciones de etanercept estabilizadas con iones metalicos. | |
| IN2012DE00888A (cs) | ||
| MX2016010056A (es) | 6-heteroariloxi o 6-ariloxi-quinolina-2-carboxamidas y metodos de uso. | |
| MY160249A (en) | Fatty acid fumarate derivatives and their uses | |
| UA107865C2 (ru) | Гетероциклические карбоксамиды | |
| MX355428B (es) | Formas cristalinas del acido [ (4-hidroxi-1-metil-7-fenoxi-isoquin olin-3-carbonil) -amino] -acetico inhibidor de prolil hidroxilasa. | |
| IN2015DN01547A (cs) | ||
| PH12015502154A1 (en) | Composition for oral cavity | |
| SG10201805198TA (en) | 18f - fluciclovine compositions in citrate buffers | |
| PH12015500334A1 (en) | Azaindole carboxylic acid amides and azaindole thiocarboxylic acid amides for use as insecticides and acaricides | |
| WO2014053401A3 (en) | Method of improving plant health | |
| BR112014002940A2 (pt) | uso e composição agroquímica de dibutilamidas de ácido carboxílico | |
| MY168438A (en) | Handy calco-magnesian suspension | |
| MX348979B (es) | Agente de control de enfermedades de las plantas. | |
| SA518391664B1 (ar) | تركيبة لتقييد تكون و/ أو تكتل هيدرات الغاز | |
| MX2015006223A (es) | Composiciones farmaceuticas de inhibidores cetp. | |
| MX350024B (es) | Formas polimorfas del ácido 4-{[4-({[4-(2,2,2-trifluoroetoxi)-1,2- benzisoxazol-3-il]oxi}metil)piperidin-1-il]metil}-tetrahidro-2h-p iran-4-carboxílico. | |
| PH12016502544B1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
| MX2013004878A (es) | N-hetarilmetil pirazolilcarboxamidas. | |
| IN2014DN06122A (cs) | ||
| UA114082C2 (xx) | Спосіб одержання водорозчинних селеноглікопротеїнів та композиція, що їх містить | |
| MX339727B (es) | Composicion farmaceutica que comprende un compuesto de 11-desoxi-prostaglandina y metodo para estabilizar el compuesto. | |
| WO2014166836A8 (en) | Growth hormone compound formulation | |
| PH12017500763A1 (en) | Nutritional compositions containing a prebiotic and lactoferrin and uses thereof |